Precision Clinical Medicine
Scope & Guideline
Shaping tomorrow's healthcare, today.
Introduction
Aims and Scopes
- Precision Oncology:
The journal emphasizes the development and application of precision medicine strategies in oncology, including the use of biomarkers, genomic profiling, and personalized treatment plans to enhance cancer care. - Multi-Omics Approaches:
There is a strong focus on multi-omics methodologies, integrating genomics, transcriptomics, proteomics, and metabolomics to understand complex diseases and develop targeted interventions. - Innovative Therapeutics:
Research on novel therapeutic strategies, including gene therapy, immunotherapy, and small-molecule drugs, is a key area of interest, with an emphasis on their application in precision medicine. - Artificial Intelligence and Machine Learning:
The utilization of AI and machine learning techniques for data analysis, predictive modeling, and enhancing diagnostic accuracy is a prominent theme in the journal. - Translational Research:
The journal aims to bridge the gap between laboratory research and clinical application, promoting studies that translate basic science discoveries into practical clinical solutions. - Chronic Disease Management:
There is a focus on understanding and managing chronic diseases such as diabetes, cardiovascular diseases, and inflammatory bowel diseases through precision medicine approaches.
Trending and Emerging
- Exosomal and Circulating Biomarkers:
There is an increasing emphasis on the role of exosomal and circulating biomarkers in disease diagnosis and prognosis, particularly in cancer and metabolic diseases, highlighting their potential as non-invasive diagnostic tools. - Integrative Machine Learning Applications:
The application of advanced machine learning techniques for data integration and predictive modeling in clinical settings is on the rise, showcasing the journal's commitment to leveraging technology for improved patient outcomes. - Gut Microbiota and Disease Interactions:
Research exploring the influence of gut microbiota on various diseases, including inflammatory bowel disease and metabolic disorders, is becoming more prominent, reflecting a growing interest in the microbiome's role in precision medicine. - Immunotherapy Innovations:
The journal is increasingly publishing studies on novel immunotherapeutic approaches, indicating a rising trend in the exploration of immune-based treatments for cancer and autoimmune diseases. - Personalized Approaches to Chronic Diseases:
There is a notable increase in research focused on personalized strategies for managing chronic diseases, including diabetes, cardiovascular diseases, and neurodegenerative disorders, aligning with the journal's precision medicine goals.
Declining or Waning
- Traditional Single-Omics Studies:
Research that relies solely on single-omics approaches has become less prominent as the field moves towards integrated multi-omics studies for more comprehensive insights into disease mechanisms. - General Population Health Studies:
While population health remains important, there is a noticeable decrease in studies that do not apply precision medicine principles, as the journal prioritizes research with specific, targeted clinical applications. - Basic Science Without Clinical Relevance:
Papers focused on basic science without a clear translational or clinical application have become less frequent, as the journal increasingly favors studies that demonstrate direct relevance to patient care. - Non-Genomic Biomarkers:
The exploration of non-genomic biomarkers has waned, possibly due to the growing prominence of genomic and molecular markers that offer more precise insights into disease processes. - Aging Research:
While still relevant, traditional aging research has seen a decline in focus within the context of precision medicine, as the journal shifts towards more specific applications of precision approaches in age-related diseases.
Similar Journals
Med
Pioneering Interdisciplinary Insights in Medicine.Med, an esteemed journal published by CELL PRESS, stands at the forefront of interdisciplinary medical research, making significant contributions to the field of Medicine since its inception in 2020. With an impressive Q1 ranking in the Medicine (miscellaneous) category and a notable 96th percentile ranking in General Medicine according to Scopus, this journal is dedicated to disseminating high-quality research that advances medical knowledge and practice. Med provides a platform where researchers, professionals, and students can share their findings and insights, fostering a collaborative environment that bridges various aspects of medicine. While offering a comprehensive body of research, Med is committed to promoting open communication within the scientific community, ensuring that valuable information is accessible to those who seek to enhance their understanding and application of medical science. With a strong presence in the United States and a global readership, Med is poised to influence the future of healthcare significantly.
Cancer Management and Research
Advancing oncology through innovative research.Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.
JCO Precision Oncology
Elevating Treatment Strategies Through Genetic InsightsJCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.
BRIEFINGS IN BIOINFORMATICS
Transforming Data into Discoveries in Life SciencesBRIEFINGS IN BIOINFORMATICS is a premier academic journal dedicated to the dynamic field of bioinformatics, published by Oxford University Press. With a prestigious standing reflected in its Q1 quartile rankings in both Information Systems and Molecular Biology, this journal serves as an essential resource for researchers, professionals, and students eager to explore the intersection of biology and computational sciences. The journal not only publishes high-impact research articles but also reviews and critical commentaries that push the boundaries of understanding in bioinformatics. As it converges its objectives towards fostering innovation and knowledge dissemination from 2000 to 2024, BRIEFINGS IN BIOINFORMATICS offers rich insights that remain pivotal to advancements in genomic studies, data integration, and computational tools. Its ranking in the top percentiles of Scopus—30th among 394 in Computer Science and 44th among 410 in Molecular Biology—underscores the journal's influential presence in the academic community. Engaging with the latest research and trends, this journal is integral for anyone invested in the future of life sciences and data analytics.
Frontiers in Neurology
Pioneering Insights in Neurology and NeuroscienceFrontiers in Neurology is a premier open-access journal dedicated to the advancement of research in the field of neurology, published by FRONTIERS MEDIA SA since 2010. With the ISSN 1664-2295 and an international reach established from its base in Lausanne, Switzerland, this journal has rapidly become a vital resource for neurologists and neuroscientists alike, presenting high-quality research that addresses critical developments in clinical and experimental neurology. Holding a solid Q2 quartile ranking in both neurology and clinical neurology, Frontiers in Neurology demonstrates substantial influence, evidenced by its respectable Scopus rankings—151st in clinical neurology and 77th in neuroscience neurology. The journal employs robust peer review practices to ensure rigor and integrity, while its open-access model fosters widespread dissemination of knowledge. By facilitating interdisciplinary dialogue and empowering research efforts, this journal not only supports the academic community but also contributes to the advancement of treatment and understanding of neurological disorders.
JOURNAL OF ORAL PATHOLOGY & MEDICINE
Shaping the Future of Oral Pathology and MedicineWelcome to the JOURNAL OF ORAL PATHOLOGY & MEDICINE, a distinguished publication dedicated to advancing knowledge within the realms of oral pathology and medicine. Published by WILEY since 1972, this journal has established itself as a critical resource for researchers and practitioners alike, covering a broad spectrum of topics related to oral health and disease. With an impressive array of rankings, including Q1 status in categories such as Oral Surgery and Periodontics, and a prominent position in Otorhinolaryngology, the journal is recognized for its substantial contributions to these fields. Although currently not open access, it remains pivotal in disseminating vital research findings, fostering collaboration and innovation among healthcare professionals. The interdisciplinary scope of the journal also supports its high impact factor and robust Scopus rankings, including a 92nd percentile in Otorhinolaryngology. By providing a platform for original research and reviews, the JOURNAL OF ORAL PATHOLOGY & MEDICINE plays an essential role in shaping future advancements in oral health sciences.
SEMINARS IN LIVER DISEASE
Elevating the discourse in liver disease management.SEMINARS IN LIVER DISEASE is a premier journal dedicated to advancing the field of hepatology, published by THIEME MEDICAL PUBL INC. Established in 1981, it has become a respected resource within the academic community, providing high-quality peer-reviewed articles that cover a broad range of topics related to liver diseases. With an impressive impact factor and recognized as a Q1 journal in the hepatology category, it ranks 17th out of 82 journals in the field, placing it in the top 21% of its category according to Scopus rankings. Although it does not offer open access, the journal’s rigorous standards and extensive network ensure that it reaches a wide audience of clinicians, researchers, and students, fostering knowledge and innovation in liver disease management. The journal's objectives focus on disseminating critical insights and promoting informed discussions that can pave the way for future research and clinical advancements in hepatology.
Genome Medicine
Fostering Collaboration for Genomic BreakthroughsGenome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.
Global Medical Genetics
Enhancing Global Health Through Genetic DiscoveryGlobal Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.
Biomedical Reports
Exploring the frontiers of biochemistry and genetics.Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.